| For: | Batra A, Rigo R, Sheka D, Cheung WY. Real-world evidence on adjuvant chemotherapy in older adults with stage II/III colon cancer. World J Gastrointest Oncol 2020; 12(6): 604-618 [PMID: 32699576 DOI: 10.4251/wjgo.v12.i6.604] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v12/i6/604.htm |
| Number | Citing Articles |
| 1 |
Hsin-Wu Lai, Hung-Chang Hung, Chun-Che Lin. Role of adjuvant radiotherapy in resected T4aN0 colon cancer. Journal of Radiation Research and Applied Sciences 2023; 16(3) doi: 10.1016/j.jrras.2023.100585
|
| 2 |
Lingyun Sun, Yun Xu, Nan Chen, Chunze Zhang, Aiwen Wu, Huaqing Wang, Yutong Fei, Peng Shu, Dechang Diao, Jianping Cheng, Yuping Chu, Tianshu Liu, Wei Wang, Ye Yuan, Baozhu Zeng, Yang Cao, Shundong Cang, Huijuan Cao, Tong Zhang, Yang Zheng, Cun’en Wu, Shaoyong Liu, Bin He, Yunzi Yan, Shaohua Yan, Na Wu, Chunhui Ning, Rongyan Peng, Andrew S. Epstein, Samuel Cytryn, Jun J. Mao, Yufei Yang. Chinese herbal medicine (JianPi-BuShen) and completion rate of adjuvant chemotherapy for patients with stage II and III colon cancer: A randomized clinical trial. European Journal of Cancer 2024; 213 doi: 10.1016/j.ejca.2024.115109
|
| 3 |
Dina Ioffe, Efrat Dotan. Contemporary Approaches to the Care of Older Adults with Gastrointestinal Cancers. Advances in Oncology 2026; 6(1) doi: 10.1016/j.yao.2026.01.010
|
| 4 |
Dina Ioffe, Efrat Dotan. Guidance for Treating the Older Adults with Colorectal Cancer. Current Treatment Options in Oncology 2023; 24(6) doi: 10.1007/s11864-023-01071-6
|
| 5 |
Yakup Duzkopru, Özlem Doğan. Stage II-III colorectal cancer in geriatric patients: Clinicopathological features and chemotherapy utilization. Turkish Journal of Clinics and Laboratory 2025; 16(1) doi: 10.18663/tjcl.1647734
|
| 6 |
Dylan E. O'Sullivan, Winson Y. Cheung, Devon J. Boyne, Tamer N. Jarada, Patricia A. Tang, Sharlene Gill, Robert J. Hilsden, Darren R. Brenner. Treatment patterns and survival outcomes of early-onset colorectal cancer patients in Alberta, Canada: a population-based study. Cancer Treatment and Research Communications 2022; 32 doi: 10.1016/j.ctarc.2022.100585
|
| 7 |
Tomoya Kataoka, Taiki Mori, Jun Suzuki, Yuto Kawaki, Yohei Kito, Yuji Hotta, Yoshihiro Kawade, Yasuhiro Maeda, Kazunori Kimura. Oxaliplatin, an Anticancer Agent, Causes Erectile Dysfunction in Rats due to Endothelial Dysfunction. The Journal of Sexual Medicine 2021; 18(8) doi: 10.1016/j.jsxm.2021.06.004
|
| 8 |
Omar Abdel-Rahman, Patricia A. Tang, Sheryl Koski. Hospitalizations among early-stage colon cancer patients receiving adjuvant chemotherapy: a real-world study. International Journal of Colorectal Disease 2021; 36(9) doi: 10.1007/s00384-021-03952-4
|
| 9 |
Juan M. Roman-Belmonte, Hortensia De la Corte-Rodriguez, E. Carlos Rodriguez-Merchan, Aranzazu Vazquez-Sasot, Beatriz A. Rodriguez-Damiani, Cristina Resino-Luís, Francisco Sanchez-Laguna. The three horizons model applied to medical science. Postgraduate Medicine 2022; 134(8) doi: 10.1080/00325481.2022.2124086
|
| 10 |
Hillary L. Simon, Thais Reif de Paula, Zachary A. Spigel, Deborah S. Keller. Factors Associated With Adjuvant Chemotherapy Noncompliance and Survival in Older Adults With Stage III Colon Cancer. Diseases of the Colon & Rectum 2023; 66(9) doi: 10.1097/DCR.0000000000002656
|
| 11 |
Omar Abdel-Rahman, Karen King, Andrew Scarfe. Real-world Patterns of Adjuvant Chemotherapy Following Neoadjuvant Chemoradiation for Patients With Resected Rectal Adenocarcinoma. American Journal of Clinical Oncology 2021; 44(8) doi: 10.1097/COC.0000000000000834
|
| 12 |
Tomoya Kataoka, Yuto Kawaki, Yohei Kito, Jun Suzuki, Taiki Mori, Yuji Hotta, Akimasa Sanagawa, Yoshihiro Kawade, Yasuhiro Maeda, Yoko Furukawa-Hibi, Kazunori Kimura. Gosha-Jinki-Gan Improved Erectile Dysfunction Caused by Anti-Cancer Agent Oxaliplatin by Decreasing Transcriptional Expression of Phosphodiesterase-5 in Rats. Sexual Medicine 2022; 10(2) doi: 10.1016/j.esxm.2021.100484
|
| 13 |
Julia Frebault, Alexander Troester, Michael Horsey, Sarah L. Mott, Schelomo Marmor, Arjun Gupta, Imran Hassan, Pridvi Kandagatla, Paolo Goffredo. Adjuvant chemotherapy in older patients with stage II and III colon cancers: Is less more?. Journal of Gastrointestinal Surgery 2025; 29(9) doi: 10.1016/j.gassur.2025.102149
|
| 14 |
Kunpeng Li, Ya-Jie Dai, Haifeng Zhang, Zhigang Zhang. YAP1 activates SLC2A1 transcription and augments the malignant behavior of colorectal cancer cells by activating the Wnt/β-catenin signaling pathway. Cell Division 2025; 20(1) doi: 10.1186/s13008-025-00148-y
|
| 15 |
Maurizio Capuozzo, Carmine Picone, Francesco Sabbatino, Mariachiara Santorsola, Francesco Caraglia, Domenico Iervolino, Roberto Sirica, Oreste Gualillo, Giordana Di Mauro, Rosa Castiello, Monica Ianniello, Alessia Maria Cossu, Angela Nebbioso, Lucia Altucci, Francesco Izzo, Renato Patrone, Andrea Belli, Massimiliano Berretta, Marco Cascella, Francesco Perri, Anna Chiara Carratù, Guglielmo Nasti, Massimo Di Maio, Antonio Giordano, Giovanni Savarese, Michele Caraglia, Alessandro Ottaiano. Genetic, Epidemiological, Clinical, and Therapeutic Trajectories in Colon and Rectal Cancers. Cancers 2025; 17(21) doi: 10.3390/cancers17213438
|
| 16 |
Scott F. Huntington, Justin T. Puckett, Beenish S. Manzoor, Nnadozie Emechebe, Sophia S. Li, Sachin Kamal-Bahl, Carolina Reyes, Holly Budlong, Jalpa A. Doshi. Real-World Overall Survival and Time to Next Treatment Among Medicare Beneficiaries with Chronic Lymphocytic Leukemia in the Frontline Setting. Cancers 2026; 18(12) doi: 10.3390/cancers18121902
|
| 17 |
María Teresa Antonio Rebollo. Elderly patient with colorectal cancer: decision making. Revisiones en Cáncer 2026; doi: 10.20960/revcancer.00139
|